Author: Chabala, Chishala
Author: Court, Richard Gray
Similar Items: A pharmacometric approach to optimal use of second line drugs for multidrug-resistant tuberculosis
- Accuracy and impact of the MTBDRplus v2 and MTBDRsl v2 line probe assays for the detection of first-line and second-line drug resistant tuberculosis
- Evaluation of rapid low-cost colorimetric methods for diagnosis of multidrug-resistant tuberculosis in limited-resource settings
- Resistance to new tuberculosis drugs
- Deciphering the physiology of drug tolerant and resistant Mycobacterium tuberculosis
- Defining the role of efflux pump inhibitors on anti-TB drugs in Rifampicin resistant clinical Mycobacterium Tuberculosis isolates
- Characterisation of phenotypic and genotypic resistance to new and re-purposed tuberculosis drugs in the Western Cape, South Africa
Similar Items: Strategies for optimising TB-HIV co-treatment in children and adolescents with drug-susceptible tuberculosis on rifampicin-based standard regimens
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
- Nonlinear mixed-effects modelling of drug-drug interactions between antiretroviral therapy and tuberculosis treatment
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Diagnostic outcomes of CT-guided lung biopsy in an HIV and TB co-infection prevalent region